Pfizer earnings were $8.0B for the trailing 12 months ending Dec 31, 2024, with 273.7% growth year over year. The latest PFE earnings report on Dec 31, 2024 announced Q4 2024 earnings of $410.0M, down 90.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PFE reported annual earnings of $8.0B, with 279% growth.
PFE past earnings growth
How has PFE's earnings growth performed historically?
On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q4 2024 earnings per share (EPS) of $0.07, up 111.86% year over year. Total PFE earnings for the quarter were $410.00 million. In the same quarter last year, Pfizer's earnings per share (EPS) was -$0.59.
As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $8.03 billion, a 279% increase year over year.
What was PFE's earnings growth in the past year?
As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown 273.68% year over year. This is 93.91 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 367.59%. PFE earnings in the past year totalled $8.03 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.